Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial-Reference-Cited by-同舟云学术

Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial

Published:2021-10-19 Issue: Volume: Page:
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Roberts Sarah T.¹^ORCID,Hawley Imogen¹,Luecke Ellen¹,Mensch Barbara²,Wagner Theresa³,Hoesley Craig⁴,McClure Tara⁵,Dominguez Islas Clara P.⁶,Piper Jeanna M.⁷,Liu Albert Y.³⁸,van der Straten Ariane¹⁸,

Affiliation:

1. Women's Global Health Imperative (WGHI), RTI International, Berkeley, California, USA.

2. Population Council, New York, New York, USA.

3. Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA.

4. Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.

5. FHI360, Durham, North Carolina, USA.

6. Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

7. Division of AIDS, National Institutes of Health, Bethesda, Maryland, USA.

8. Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jwh.2021.0121

Reference41 articles.

1. 1. UNAIDS data 2020. Geneva, Switzerland: UNAIDS, 2020.

2. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

3. Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

4. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

5. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe;AIDS and Behavior;2024-07-25

2. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027);BMC Public Health;2024-05-31

3. High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda;Frontiers in Global Women's Health;2024-04-11

4. Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-01-01

5. Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability;Frontiers in Reproductive Health;2023-07-06